Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDF
0
Australia
0
South Africa
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Fesoterodine
2. Toviaz
1. 286930-03-8
2. Toviaz
3. (r)-fesoterodine Fumarate
4. Spm 907
5. Spm 8272
6. Spm-907
7. Spm-8272
8. Fesoterodine Maleate
9. Fesoterodine (fumarate)
10. Eos72165s7
11. (e)-but-2-enedioic Acid;[2-[(1r)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate
12. Propanoic Acid, 2-methyl-, 2-[(1r)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl Ester, (2e)-2-butenedioate (1:1)
13. 286930-03-8 (fumarate); 286930-02-7 (free Base)
14. Fesoterodine Fumarate [usan]
15. Unii-eos72165s7
16. Fesoterodine Fumarate [usan:jan]
17. (e)-but-2-enedioic Acid,[2-[(1r)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate
18. Toviaz (tn)
19. (r)-fesoterodinefumarate
20. Mls003915638
21. Schembl814971
22. Fesoterodine Fumarate - Toviaz
23. Schembl1993632
24. Chembl1201765
25. Dtxsid00904655
26. Bcpp000231
27. Fesoterodine Fumarate (jan/usan)
28. Fesoterodine Fumarate [mi]
29. Hms3884d11
30. Fesoterodine Fumarate [jan]
31. Amy37611
32. Hy-a0030
33. Bdbm50248002
34. Fesoterodine Fumarate [vandf]
35. Mfcd12756004
36. S2240
37. Fesoterodine Fumarate [mart.]
38. Akos005146248
39. Akos015855886
40. Fesoterodine Fumarate [who-dd]
41. Ac-3486
42. Bcp9000682
43. Ccg-269901
44. Cs-0822
45. Ks-1298
46. 2-((1r)-3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl Isobutyrate
47. Fesoterodine Fumarate [ema Epar]
48. 2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl 2-methylpropanoate Hydrogen (2e)-butenedioate (salt)
49. Propanoic Acid, 2-methyl-, 2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl Ester, (2e)-2-butenedioate (1:1) (salt)
50. Smr002544691
51. Fesoterodine Fumarate [orange Book]
52. Pf-00695838
53. D08923
54. 930f038
55. A846296
56. Q27277274
57. 2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl 2-methylpropanoate Hydrogen(2e)-butenedioate (salt)
58. Fesoterodinefumarate;(r)-fesoterodine Fumarate;2-methylpropanoic Acid 2-[(1r)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl Ester (2e)-2-butenedioate
59. Propanoic Acid,2-methyl ,2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl Ester,(2e)-2-butenedioate (1:1)(salt)
Molecular Weight | 527.6 g/mol |
---|---|
Molecular Formula | C30H41NO7 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 13 |
Exact Mass | 527.28830265 g/mol |
Monoisotopic Mass | 527.28830265 g/mol |
Topological Polar Surface Area | 124 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 610 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Toviaz |
PubMed Health | Fesoterodine (By mouth) |
Drug Classes | Urinary Antispasmodic |
Drug Label | Toviaz contains fesoterodine fumarate and is an extended-release tablet. Fesoterodine is rapidly de-esterified to its active metabolite (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, or 5-hydroxymethyl tolterodine, which is a musca... |
Active Ingredient | Fesoterodine fumarate |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 8mg; 4mg |
Market Status | Prescription |
Company | Pfizer |
2 of 2 | |
---|---|
Drug Name | Toviaz |
PubMed Health | Fesoterodine (By mouth) |
Drug Classes | Urinary Antispasmodic |
Drug Label | Toviaz contains fesoterodine fumarate and is an extended-release tablet. Fesoterodine is rapidly de-esterified to its active metabolite (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, or 5-hydroxymethyl tolterodine, which is a musca... |
Active Ingredient | Fesoterodine fumarate |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 8mg; 4mg |
Market Status | Prescription |
Company | Pfizer |
Treatment of the symptoms (increased urinary frequency and / or urgency and / or urgency incontinence) that may occur in patients with overactive-bladder syndrome.
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
G04BD11
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Fesoterodine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fesoterodine, including repackagers and relabelers. The FDA regulates Fesoterodine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fesoterodine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fesoterodine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fesoterodine supplier is an individual or a company that provides Fesoterodine active pharmaceutical ingredient (API) or Fesoterodine finished formulations upon request. The Fesoterodine suppliers may include Fesoterodine API manufacturers, exporters, distributors and traders.
click here to find a list of Fesoterodine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fesoterodine DMF (Drug Master File) is a document detailing the whole manufacturing process of Fesoterodine active pharmaceutical ingredient (API) in detail. Different forms of Fesoterodine DMFs exist exist since differing nations have different regulations, such as Fesoterodine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fesoterodine DMF submitted to regulatory agencies in the US is known as a USDMF. Fesoterodine USDMF includes data on Fesoterodine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fesoterodine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fesoterodine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fesoterodine Drug Master File in Korea (Fesoterodine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fesoterodine. The MFDS reviews the Fesoterodine KDMF as part of the drug registration process and uses the information provided in the Fesoterodine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fesoterodine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fesoterodine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fesoterodine suppliers with KDMF on PharmaCompass.
A Fesoterodine written confirmation (Fesoterodine WC) is an official document issued by a regulatory agency to a Fesoterodine manufacturer, verifying that the manufacturing facility of a Fesoterodine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fesoterodine APIs or Fesoterodine finished pharmaceutical products to another nation, regulatory agencies frequently require a Fesoterodine WC (written confirmation) as part of the regulatory process.
click here to find a list of Fesoterodine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fesoterodine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fesoterodine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fesoterodine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fesoterodine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fesoterodine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fesoterodine suppliers with NDC on PharmaCompass.
Fesoterodine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fesoterodine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fesoterodine GMP manufacturer or Fesoterodine GMP API supplier for your needs.
A Fesoterodine CoA (Certificate of Analysis) is a formal document that attests to Fesoterodine's compliance with Fesoterodine specifications and serves as a tool for batch-level quality control.
Fesoterodine CoA mostly includes findings from lab analyses of a specific batch. For each Fesoterodine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fesoterodine may be tested according to a variety of international standards, such as European Pharmacopoeia (Fesoterodine EP), Fesoterodine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fesoterodine USP).
LOOKING FOR A SUPPLIER?